Journal of Dentistry-Shiraz University of Medical Sciences. 2011; 12 (4): 376-387
en Persa
| IMEMR
| ID: emr-194606
ABSTRACT
Statement of Problems Bisphosphonates are a class of agents used in treating a variety of bone diseases, including osteoporosis, multiple myeloma and hypocalcemia due to malignancy. Despite the benefits related to the use of these medications, in recent years, numerous cases of bisphosphonate-related osteonecrosis of the jaws [BRONJ] of patients treated with oral/IV bisphosphonates have been reported. The BRONJ phenomenon is a serious complication, presenting as an exposure of alveolar bone either spontaneously or secondary to invasive oral surgical procedures
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Persa
Revista:
J. Dent.-Shiraz Univ. Med. Sci.
Año:
2011
Similares
MEDLINE
...
LILACS
LIS